share_log

BriaCell Therapeutics Shares Are Trading Higher After the Company Announced It Dosed the First Patient in Its Phase 1/2 Study of Bria-OTS.

BriaCell Therapeutics Shares Are Trading Higher After the Company Announced It Dosed the First Patient in Its Phase 1/2 Study of Bria-OTS.

BriaCell Therapeutics股價上漲,因公司宣佈在Bria-OTS的1/2期研究中給第一位患者注射了藥物。
Benzinga ·  2024/11/22 00:47

BriaCell Therapeutics Shares Are Trading Higher After the Company Announced It Dosed the First Patient in Its Phase 1/2 Study of Bria-OTS.

BriaCell Therapeutics的股票在公司宣佈其在Bria-OTS的1/2期研究中給第一位患者用藥後,交易價格上漲。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論